Consistent with results from the Marisa dataset, we found from the TCGA dataset that high GPER1 expression significantly associated with shorter survival in stage III and IV female CRC patients whereas no association was observed at stage I and II (Figure 5). The gene discussed is GPER1; the disease is colorectal carcinoma.